Helus Pharma Inc

HELPNASDAQ · USD
8.96USD+0.57 (+6.80%)
3210

Helus Pharma Inc (HELP) Option Chain

Read more

Tracking the HELP option chain helps you see every strike and expiry on Helus Pharma Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of HELP options activity at a glance. Use our scanner to monitor the HELP option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For HELP stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where HELP options are being actively traded, and where they are not.

Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
29.57000.292.961.005.506.00-28.49—4.900.004.900070.43
48.641,46210.061.460.502.557.50-10.610.651.100.000.88371,03751.36
64.67061.500.001.201.809.00+7.270.204.900.042.510235.33
73.0359001.130.000.252.0010.00+19.192.003.001.041.46367226.97
79.63004.900.00—4.9011.00+31.111.055.502.041.240020.37

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank—
  • Market cap (M$)613
  • 52 weeks high-44.62%
  • 52 weeks low123.14%
  • Analyst recommendationStrong Buy
    1.11
  • Target price$43.75
    388.28% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-12
  • P/E—
  • Future P/E—
  • EPS (ttm)-4.25
  • EPS growth next 5 years27.67%

As of Nov 5, 2026